Sito Bio(SZ:300583)2025-05-15 09:58Product Line and Applications - The company's intermediate product line includes five main series: Androstenedione (AD), Androstenedione (ADD), 9-Hydroxyandrostenedione (9OH-AD), 17α-hydroxy derivatives (A ring), and Dihydrotestosterone (BA), primarily used in the production of steroid drugs for various medical applications [1][2]. Quality Control and Management - The company adheres to strict quality management systems across all production stages, implementing international GMP standards to ensure product quality stability and consistency [2][3]. - In 2024, the company reported a net cash flow from operating activities of approximately ¥194.46 million, a 309.44% increase from the previous year, attributed to reduced cash payments for purchased goods and increased receipts from sales [4]. Research and Development - R&D investments have steadily increased from ¥50.21 million in 2022 to ¥58.38 million in 2024, supporting the company's industrial upgrades and performance growth [4][5]. - The company has accumulated nearly ¥400 million in R&D investments, with over 90 patents, including 25 invention patents, enhancing its competitive edge in the market [6]. Environmental and Sustainability Initiatives - The company is recognized as a national-level green factory, utilizing synthetic biology and genetic engineering technologies to improve environmental sustainability in production processes [3][5]. - Various energy-saving measures have been implemented to reduce carbon emissions, including advanced technology adoption to lower material consumption and pollution [5]. Market Position and Strategy - The global steroid hormone drug market is growing at over 10% annually, with the company positioned to capitalize on this trend, as China's steroid hormone raw material production accounts for about one-third of the global total [7][9]. - The company aims to integrate its operations across the pharmaceutical value chain, focusing on the production of intermediates, raw materials, and finished formulations [10][11]. Employee and Labor Relations - The company emphasizes employee rights protection, adhering to labor laws and establishing a comprehensive human resource management system to foster a harmonious labor relationship [11]. Future Outlook - The company plans to expand its international market presence, with overseas revenue accounting for 18.55% of total revenue in 2024, and aims to register multiple raw materials in the US and EU to facilitate exports [11].